FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992682983> ?p ?o ?g. }

• W1992682983 endingPage "393" @default.
• W1992682983 startingPage "373" @default.
• W1992682983 abstract "1. The role of adenosine receptors in reducing calcium currents (ICa) and in triggering presynaptic inhibition was studied using whole-cell patch-clamp techniques to record ICa and synaptic currents from the cell bodies of cultured rat hippocampal pyramidal neurones. Recordings of intracellular Ca2+ using the indicator dye Fura-2 were used to obtain further insights into the actions of adenosine agonists. 2. The adenosine analogue 2-chloroadenosine (2-CA) reduced ICa in these neurones. This action was also evident when Ba2+ was used as the charge carrier through Ca2+ channels. Adenosine also reduced the influx of Ca2+ into the cell body during a depolarizing voltage-clamp pulse as measured with Fura-2. The potency of various adenosine receptor agonists was as follows: cyclopentyladenosine greater than cyclohexyl-adenosine greater than or equal to R-phenylisopropyladenosine greater than 2-CA greater than S-phenylisopropyladenosine, consistent with the pharmacological profile of an A1 adenosine receptor. 3. The specific A1 receptor antagonist cyclopentyltheophylline (CPT) blocked the actions of 2-CA on ICa in a competitive fashion. 4. The actions of 2-CA on ICa were abolished by pre-incubation of cultured cells with pertussis toxin (PTX; 250 ng/ml). Intracellular dialysis with the GTP analogue GTP-gamma-S (guanosine-5'-O-(3-thiotriphosphate] enhanced the actions of 2-CA and rendered the response irreversible. 5. Excitatory postsynaptic currents (EPSCs) were recorded from pyramidal neurones under whole-cell voltage clamp by stimulating nearby neurones with an extracellular electrode. 2-CA potently and reversibly reduced the amplitude of EPSCs. This action was shown to be due to presynaptic inhibition of neurotransmitter release. 6. The order of potency of different adenosine agonists in reducing EPSCs was as follows: cyclopentyladenosine greater than cyclohexyladenosine greater than or equal to R-phenylisopropyladenosine greater than 2-CA greater than S-phenylisopropyladenosine. CPT inhibited the action of 2-CA in a competitive fashion. 7. The effects of 2-CA on synaptic transmission were abolished by pre-treatment with 250 ng/ml PTX, indicating that a PTX-sensitive G-protein is involved in this action. 8. These results indicate that activation of adenosine receptors does induce a reduction in ICa in hippocampal pyramidal neurones. Furthermore, this effect and the reduction of excitatory synaptic transmission by adenosine analogues are both mediated by PTX-sensitive G-proteins and have identical pharmacological properties." @default.
• W1992682983 created "2016-06-24" @default.
• W1992682983 creator A5061375376 @default.
• W1992682983 creator A5066616314 @default.
• W1992682983 date "1991-04-01" @default.
• W1992682983 modified "2023-10-18" @default.
• W1992682983 title "Analysis of adenosine actions on Ca2+ currents and synaptic transmission in cultured rat hippocampal pyramidal neurones." @default.
• W1992682983 cites W1496211185 @default.
• W1992682983 cites W1546522923 @default.
• W1992682983 cites W1903396856 @default.
• W1992682983 cites W1969534867 @default.
• W1992682983 cites W1982888042 @default.
• W1992682983 cites W1987700551 @default.
• W1992682983 cites W1993940179 @default.
• W1992682983 cites W1996024251 @default.
• W1992682983 cites W1997511216 @default.
• W1992682983 cites W1998225973 @default.
• W1992682983 cites W1998633576 @default.
• W1992682983 cites W2007990537 @default.
• W1992682983 cites W2009667219 @default.
• W1992682983 cites W2010547173 @default.
• W1992682983 cites W2015426350 @default.
• W1992682983 cites W2034038906 @default.
• W1992682983 cites W2034354321 @default.
• W1992682983 cites W2036758780 @default.
• W1992682983 cites W2039753614 @default.
• W1992682983 cites W2040618621 @default.
• W1992682983 cites W2047534847 @default.
• W1992682983 cites W2055012870 @default.
• W1992682983 cites W2057537207 @default.
• W1992682983 cites W2059770348 @default.
• W1992682983 cites W2060862211 @default.
• W1992682983 cites W2064748241 @default.
• W1992682983 cites W2068617048 @default.
• W1992682983 cites W2070762029 @default.
• W1992682983 cites W2074034090 @default.
• W1992682983 cites W2080418204 @default.
• W1992682983 cites W2083068856 @default.
• W1992682983 cites W2084679742 @default.
• W1992682983 cites W2090298843 @default.
• W1992682983 cites W2101196555 @default.
• W1992682983 cites W2107208063 @default.
• W1992682983 cites W2141260882 @default.
• W1992682983 cites W2156391742 @default.
• W1992682983 cites W2158586551 @default.
• W1992682983 cites W2164808009 @default.
• W1992682983 cites W2255064238 @default.
• W1992682983 cites W2404301101 @default.
• W1992682983 cites W2404767277 @default.
• W1992682983 cites W340599019 @default.
• W1992682983 doi "https://doi.org/10.1113/jphysiol.1991.sp018515" @default.
• W1992682983 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1181467" @default.
• W1992682983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1663161" @default.
• W1992682983 hasPublicationYear "1991" @default.
• W1992682983 type Work @default.
• W1992682983 sameAs 1992682983 @default.
• W1992682983 citedByCount "161" @default.
• W1992682983 countsByYear W19926829832012 @default.
• W1992682983 countsByYear W19926829832015 @default.
• W1992682983 countsByYear W19926829832020 @default.
• W1992682983 countsByYear W19926829832021 @default.
• W1992682983 countsByYear W19926829832022 @default.
• W1992682983 crossrefType "journal-article" @default.
• W1992682983 hasAuthorship W1992682983A5061375376 @default.
• W1992682983 hasAuthorship W1992682983A5066616314 @default.
• W1992682983 hasBestOaLocation W19926829832 @default.
• W1992682983 hasConcept C100837961 @default.
• W1992682983 hasConcept C112592302 @default.
• W1992682983 hasConcept C12554922 @default.
• W1992682983 hasConcept C134018914 @default.
• W1992682983 hasConcept C147944092 @default.
• W1992682983 hasConcept C169760540 @default.
• W1992682983 hasConcept C170493617 @default.
• W1992682983 hasConcept C17077164 @default.
• W1992682983 hasConcept C181911157 @default.
• W1992682983 hasConcept C182683403 @default.
• W1992682983 hasConcept C185263204 @default.
• W1992682983 hasConcept C185592680 @default.
• W1992682983 hasConcept C197341189 @default.
• W1992682983 hasConcept C200170125 @default.
• W1992682983 hasConcept C2776991684 @default.
• W1992682983 hasConcept C2778938600 @default.
• W1992682983 hasConcept C4141045 @default.
• W1992682983 hasConcept C55493867 @default.
• W1992682983 hasConcept C67907053 @default.
• W1992682983 hasConcept C86803240 @default.
• W1992682983 hasConceptScore W1992682983C100837961 @default.
• W1992682983 hasConceptScore W1992682983C112592302 @default.
• W1992682983 hasConceptScore W1992682983C12554922 @default.
• W1992682983 hasConceptScore W1992682983C134018914 @default.
• W1992682983 hasConceptScore W1992682983C147944092 @default.
• W1992682983 hasConceptScore W1992682983C169760540 @default.
• W1992682983 hasConceptScore W1992682983C170493617 @default.
• W1992682983 hasConceptScore W1992682983C17077164 @default.
• W1992682983 hasConceptScore W1992682983C181911157 @default.
• W1992682983 hasConceptScore W1992682983C182683403 @default.
• W1992682983 hasConceptScore W1992682983C185263204 @default.
• W1992682983 hasConceptScore W1992682983C185592680 @default.

• next